Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Non-Current Assets (2016 - 2025)

Lipocine (LPCN) has disclosed Non-Current Assets for 13 consecutive years, with $143027.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Assets fell 26.42% year-over-year to $143027.0, compared with a TTM value of $662263.0 through Sep 2025, up 12.56%, and an annual FY2024 reading of $188828.0, up 35.02% over the prior year.
  • Non-Current Assets was $143027.0 for Q3 2025 at Lipocine, down from $157150.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $6.1 million in Q4 2021 and bottomed at $23753.0 in Q2 2021.
  • Average Non-Current Assets over 5 years is $1.8 million, with a median of $188828.0 recorded in 2024.
  • The sharpest move saw Non-Current Assets soared 25592.6% in 2021, then tumbled 96.39% in 2024.
  • Year by year, Non-Current Assets stood at $6.1 million in 2021, then plummeted by 44.16% to $3.4 million in 2022, then tumbled by 95.9% to $139848.0 in 2023, then surged by 35.02% to $188828.0 in 2024, then decreased by 24.26% to $143027.0 in 2025.
  • Business Quant data shows Non-Current Assets for LPCN at $143027.0 in Q3 2025, $157150.0 in Q2 2025, and $173258.0 in Q1 2025.